Marriage Counselors in Flourtown, PA Accepting Medicare
3 Marriage Counselors found. Showing 1 - 3
 Dr. Joseph L. Nines, PH.D., L.M.F.T. Marriage & Family Therapist Medicare: Accepting Medicare Assignments Practice Location: 12 E Mill Rd, Flourtown, PA 19031 Phone: 215-836-4276 Fax: 215-233-1081 |
 Dr. Erika Evans, PHD, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1407 Bethlehem Pike Fl 2, Flourtown, PA 19031 Phone: 215-527-4248 |
Denise M. Carr, M.S., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 806 Bethlehem Pike # 2a, Flourtown, PA 19031 Phone: 215-601-6271 |
News Archive
Researchers awarded $26M NIH grant to advance treatments for Ebola and Marburg
The University of Texas Medical Branch at Galveston, Profectus Biosciences, Tekmira Pharmaceuticals and the Vanderbilt University Medical Center have been awarded up to $26 million to advance treatments of the highly lethal hemorrhagic fever viruses Ebola and Marburg.
Scientists reveal new method to reprogram specific T cells
When the immune system is imbalanced, either due to overly-active cells or cells that suppress its function, it causes a wide range of diseases, from psoriasis to cancer.
Mindray Medical announces completion of Wuhan Dragonbio acquisition
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it completed the acquisition of the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. for a total cash consideration of RMB 435 million (approximately US$ 70.2 million) pursuant to the terms of the definitive agreement entered into on July 7, 2015.
AGA issues Medical Position Statement on Treatment of Barrett's Esophagus
BARRX Medical, Inc., a leader in developing minimally invasive medical devices to remove precancerous tissue from the gastrointestinal tract, reported today that the American Gastroenterological Association has issued the AGA Medical Position Statement on the Treatment of Barrett's Esophagus.
Alexza Pharmaceuticals secures $15M working capital loan from Hercules Technology Growth Capital
Alexza Pharmaceuticals, Inc. announced today that it has executed a $15 million working capital loan agreement with Hercules Technology Growth Capital. The funds available under the loan will be used for capital equipment and working capital purposes. In connection with the loan, Alexza issued Hercules warrants to purchase 376,394 shares of common stock at an exercise price of $2.69 per share, which was the 50-day average daily weighted average trading price at the time the term sheet for the loan was issued by Hercules.
› Verified 6 days ago
Counselors
Pharmacists
Clinical Social Workers
Psychologists
Dentists
Occupational Therapists
Marriage Counselors